Induced pluripotent stem cells (iPSCs) serve as a robust platform to model several human arrhythmia syndromes including atrial fibrillation (AF). However, the structural, molecular, functional, and electrophysiological parameters of patient-specific iPSC-derived atrial cardiomyocytes (iPSC-aCMs) do not fully recapitulate the mature phenotype of their human adult counterparts. The use of physiologically inspired microenvironmental cues, such as postnatal factors, metabolic conditioning, extracellular matrix (ECM) modulation, electrical and mechanical stimulation, co-culture with non-parenchymal cells, and 3D culture techniques can help mimic natural atrial development and induce a more mature adult phenotype in iPSC-aCMs. Such advances will not only elucidate the underlying pathophysiological mechanisms of AF, but also identify and assess novel mechanism-based therapies towards supporting a more ‘personalized’ (i.e. patient-specific) approach to pharmacologic therapy of AF.
ChughSSHavmoellerRNarayananKSinghDRienstraMBenjaminEJGillumRFKimY-HMcAnultyJHZhengZ-JForouzanfarMHNaghaviMMensahGAEzzatiMMurrayCJL.Worldwide epidemiology of atrial fibrillation. Circulation2014;
129:837–47
2.
StewartSMurphyNFMurphyNWalkerAMcGuireAMcMurrayJJV.Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart2004;
90:286–92
3.
MiyasakaYBarnesMEGershBJChaSSBaileyKRAbhayaratnaWPSewardJBTsangTSM.Secular trends in incidence of atrial fibrillation in Olmsted county, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation2006;
114:119–25
4.
Lloyd-JonesDMWangTJLeipEPLarsonMGLevyDVasanRSD’AgostinoRBMassaroJMBeiserAWolfPABenjaminEJ.Lifetime risk for development of atrial fibrillation: the Framingham heart study. Circulation2004;
110:1042–6
5.
DarbarDRodenDM.Genetic mechanisms of atrial fibrillation: impact on response to treatment. Nat Rev Cardiol2013;
10:317–29
6.
JanuaryCTWannLSAlpertJSCalkinsHCigarroaJEClevelandJCContiJBEllinorPTEzekowitzMDFieldMEMurrayKTSaccoRLStevensonWGTchouPJTracyCMYancyCW.AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary. Circulation2014;
130:2071–104
7.
DuytschaeverMDemolderAPhlipsTSarkozyAEl HaddadMTaghjiPKnechtSTavernierRVandekerckhoveYDe PotterT.PulmOnary vein isolation with vs. without continued antiarrhythmic drug trEatment in subjects with recurrent atrial fibrillation (POWDER AF): results from a multicentre randomized trial. Eur Heart J2018;
39:1429–37
8.
DarghosianLFreeMLiJGebretsadikTBianAShintaniAMcBrideBFSolusJMilneGCrossleyGHThompsonDVidailletHOkaforHDarbarDMurrayKTSteinCM.Effect of omega-three polyunsaturated fatty acids on inflammation, oxidative stress, and recurrence of atrial fibrillation. Am J Cardiol2015;
115:196–201
9.
DarbarDKimbroughJJawaidAMcCrayRRitchieMDRodenDM.Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome. J Am Coll Cardiol2008;
51:836–42
10.
ArgenzianoMLambersEHongLSridharAZhangMChalazanBMenonASavio-GalimbertiEWuJCRehmanJDarbarD.Electrophysiologic characterization of calcium handling in human induced pluripotent stem cell-derived atrial cardiomyocytes. Stem Cell Rep2018;
10:1867–78
11.
AbrahamRLYangTBlairMRodenDMDarbarD.Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation. J Mol Cell Cardiol2010;
48:181–90
12.
HerronTJDa RochaAMCampbellKFPonce-BalbuenaDWillisBCGuerrero-SernaGLiuQKlosMMusaHZarzosoMBizyAFurnessJAnumonwoJMironovSJalifeJ.Extracellular matrix-mediated maturation of human pluripotent stem cell-derived cardiac monolayer structure and electrophysiological function. Circ Arrhythmia Electrophysiol2016;
9:1–12
13.
Monteiro Da RochaACampbellKMironovSJiangJMundadaLGuerrero-SernaGJalifeJHerronTJ.hiPSC-CM monolayer maturation state determines drug responsiveness in high throughput pro-arrhythmia screen. Nature Sci Rep2017;
7:13834
14.
MalanDFriedrichsSFleischmannBKSasseP.Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro. Circ Res2011;
109:841–7
15.
GajTGersbachCABarbasCF.ZFN, TALEN, and CRISPR/cas-based methods for genome engineering. Trends Biotechnol2013;
31:397–405
16.
DevallaHDSchwachVFordJWMilnesJTEl-HaouSJacksonCGkatzisKElliottDAChuvaSMLopesSMummeryCLVerkerkAOPassierR.Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology. EMBO Mol Med2015;
7:394–410
17.
DevallaHDPassierR.Cardiac differentiation of pluripotent stem cells and implications for modeling the heart in health and disease. Sci Transl Med2018;
10:eaah5457
18.
LiangPSallamKWuHLiYItzhakiIGargPZhangYVittavatVLanFGuMGongTZhugeYHeCEbertADSanchez-FreireVChurkoJHuSSharmaALamCKScheinmanMMBersDMWuJC.Patient-specific and genome-edited induced pluripotent stem cell–derived cardiomyocytes elucidate single-cell phenotype of Brugada syndrome. J Am Coll Cardiol2016;
68:2086–96
19.
YangXPabonLMurryCE.Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res2014;
114:511–23
20.
SunXNunesSS.Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Methods2016;
10:21–6
21.
FericNTRadisicM.Towards adult-like human engineered cardiac tissue: maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues graphical abstract HHS public access. Adv Drug Deliv Rev2016;
96:110–34
22.
NgSYWongCKTsangSY.Differential gene expressions in atrial and ventricular myocytes: insights into the road of applying embryonic stem cell-derived cardiomyocytes for future therapies. Am J Physiol Cell Physiol2010;
299:C1234–C1249
23.
PiroddiNBelusAScelliniBTesiCGiuntiGCerbaiEMugelliAPoggesiC.Tension generation and relaxation in single myofibrils from human atrial and ventricular myocardium. Pflugers Arch2007;
454:63–73
24.
Asahi M, Kurzydlowski K, Tada M, MacLennan DH.
Sarcolipin inhibits polymerization of phospholamban to induce superinhibition of sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs). J Biol Chem2002;
388:539–47
25.
LopaschukGDJaswalJS.Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J Cardiovasc Pharmacol2010;
56:130–40
26.
ChoYMKwonSPakYKSeolHWChoiYMParkDJParkKSLeeHK.Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem Biophys Res Commun2006;
348:1472–8
27.
ChungSArrellDKFaustinoRSTerzicADzejaPP.Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. J Mol Cell Cardiol2010;
48:725–34
28.
DeberardinisRJThompsonCB.Cellular metabolism and disease: what do metabolic outliers teach us?Cell2012;
148:1132–44
29.
GrantAO.Cardiac ion channels. Circ Arrhythm Electrophysiol2009;
2:185–94
30.
TiburcyMHudsonJEBalfanzPSchlickSMeyerTLiaoMCLeventERaadFZeidlerSWingenderERieglerJWangMGoldJDKehatIWettwerERavensUDierickxPvan LaakeLWGoumansMJKhadjehSToischerKHasenfussGCoutureLAUngerALinkeWAArakiTNeelBKellerGGepsteinLWuJCZimmermannW.Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair. Circulation2017;
135:1832–47
31.
RuanJLTullochNLRazumovaMVSaigetMMuskheliVPabonLReineckeHRegnierMMurryCE.Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue. Circulation2016;
134:1557–67
32.
ScuderiGJButcherJ.Naturally engineered maturation of cardiomyocytes. Front Cell Dev Biol2017;
5:1–28
33.
BirketMJRibeiroMCKosmidisGWardDLeitoguinhoARvan de PolVDambrotCDevallaHDDavisRPMastroberardinoPGAtsmaDEPassierRMummeryCL.Contractile defect caused by mutation in MYBPC3 revealed under conditions optimized for human PSC-cardiomyocyte function. Cell Rep2015;
13:733–45
34.
ForheadAJFowdenAL.Thyroid hormones in fetal growth and prepartum maturation. J. Endocrinol2014;
221:87–103
35.
BesserRRIshahakMMayoVCarboneroDClaureIAgarwalA.Engineered microenvironments for maturation of stem cell derived cardiac myocytes. Theranostics2018;
8:124–40
YangXRodriguezMLLeonardASunLFischerKAWangYRitterhoffJZhaoLKolwiczSCPabonLReineckeHSniadeckiNJTianRRuohola-BakerHXuHMurryCE.Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Rep2019;
13:657–68
38.
CorreiaCKoshkinADuartePHuDTeixeiraADomianISerraMAlvesPM.Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Sci. Rep2017;
7:8590
39.
FeyenDAMMcKeithanWLBruyneelAANSpieringSHormannLUlmerBZhangHBrigantiFSchweizerMHegyiBLiaoZPolonenRGinsburgKSLamCKSerranoRWahlquistCKreymermanAVuMAmatyaPLBehrensCSRanjbarvarziri MaasRGCGreenhawMBernsteinDWuJCBersDMEschenhagenTMetalloCMMercoloaM.Metabolic maturation media improve physiological function of human iPSC-derived cardiomyocytes. Cell Rep2020;
32:107925
40.
NakanoHMinamiIBraasDPappoeHWuXSagadevanAVergnesLFuKMorselliMDunhamCDingXStiegAZGimzewskiJKPellegriniMClarkPMReueKLusisAJRibaletBKurdistaniSKChristofkHNakatsujiMNakanoA.Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis. Elife2017;
6:e29330
41.
HorikoshiYYanYTerashviliMWellsCHorikoshiHFujitaSBosnjakZJBaiX.Fatty acid-treated induced pluripotent stem cell-derived human cardiomyocytes exhibit adult cardiomyocyte like energy metabolism phenotypes. Cells2019;
8:1095–116
42.
MachirajuPGreenwaySC.Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes. World J Stem Cells2019;
11:33–43
43.
HuDLindersAYamakACorreiaCKijlstraJDGarakaniAXiaoLMilanDJvan der MeerPSerraMAlvesPMDomianIJ.Metabolic maturation of human pluripotent stem cell-derived cardiomyocytes by inhibition of HIF1α and LDHA. Circ Res2018;
123:1066–79
44.
LinaskKKLashJW.A role for fibronectin in the migration of avian precardiac cells. I. Dose-dependent effects of fibronectin antibody. Dev Biol1988;
129:315–23
45.
WilliamsCQuinnKPGeorgakoudiIBlackLD.Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro. Acta Biomater2014;
10:194–204
46.
PaolettiCDivietoCChionoV.Impact of biomaterials on differentiation and reprogramming approaches for the generation of functional cardiomyocytes. Cells2018;
7:114–39
47.
BianWJackmanCPBursacN.Controlling the structural and functional anisotropy of engineered cardiac tissues. Biofabrication2014;
6:024109
48.
SalickMRNapiwockiBNShaJKnightGTChindhySAKampTJAshtonRSCroneWC.Micropattern width dependent sarcomere development in human ESC-derived cardiomyocytes. Biomaterials2014;
35:4454–64
49.
RapeADGuoWHWangYL.The regulation of traction force in relation to cell shape and focal adhesions. Biomaterials2011;
32:2043–51
50.
ChanYCTingSLeeYKNgKMZhangJChenZSiuCWOhSKWTseHF.Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells. J Cardiovasc Trans Res2013;
6:989–99
51.
KujalaKAholaAPekkanen-MattilaMIkonenLKerkeläEHyttinenJAalto-SetäläK.Electrical field stimulation with a novel platform: effect on cardiomyocyte gene expression but not on orientation. Int J Biomed Sci2012;
8:109–20
52.
MaRLiangJHuangWGuoLCaiWWangLPaulCYangHTKimHWWangY.Electrical stimulation enhances cardiac differentiation of human induced pluripotent stem cells for myocardial infarction therapy. Antioxid Redox Signal2018;
28:371–84
53.
Ronaldson-BouchardKYeagerKTelesDChenTMaSSongLJMorikawaKWobmaHMVasciaveoARuizECYazawaMVunjak-NovakovicG.Engineering of human cardiac muscle electromechanically matured to an adult-like phenotype. Nat Protoc2019;
14:2781–817
54.
MartherusRSRMVanherleSJVTimmerEDJZeijlemakerVABroersJLSmeetsHJGeraedtsJPAyoubiTAY.Electrical signals affect the cardiomyocyte transcriptome independently of contraction. Physiol Genomics2010;
42A:283–9
55.
Ronaldson-BouchardKMaSPYeagerKChenTSongLJSirabellaDMorikawaKTelesDYazawaMVunjak-NovakovicG.Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature2018;
556:239–43
56.
NunesSSMiklasJWLiuJAschar-SobbiRXiaoYZhangBJiangJMasséSGagliardiMHsiehAThavandiranNLaflammeMANanthakumarKGrossGJBackxPHKellerGRadisicM.Biowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes. Nat Methods2013;
10:781–7
57.
MihicALiJMiyagiYGagliardiMLiSHZuJWeiselRDKellerGLiRK.The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes. Biomaterials2014;
35:2798–808
58.
NguyenMDTinneyJPYeFElnakibAAYuanFEl-BazASethuPKellerBBGiridharanGA.Effects of physiologic mechanical stimulation on embryonic chick cardiomyocytes using a microfluidic cardiac cell culture model. Anal Chem2015;
87:2107–13
59.
TullochNLMuskheliVRazumovaMVKorteFSRegnierMHauchKDPabonLReineckeHMurryCE.Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res2011;
109:47–59
60.
NagAC.Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios1980;
28:41–61
61.
BergmannOZdunekSFelkerASalehpourMAlkassKBernardSSjostromSLSzewczykowskaMJackowskaTDos RemediosCMalmTAndräMJashariRNyengaardJRPossnertGJovingeSDruidH.FrisénJ.Dynamics of cell generation and turnover in the human heart. Cell2015;
161:1566–75
62.
CamellitiPBorgTKKohlP.Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res2005;
65:40–51
63.
SoudersCABowersSLKBaudinoTA.Cardiac fibroblast: the renaissance cell. Circ Res2009;
105:1164–76
64.
SánchezJGomezJFMartinez-MateuLRomeroLSaizJTrenorB.Heterogeneous effects of fibroblast-myocyte coupling in different regions of the human atria under conditions of atrial fibrillation. Front Physiol2019;
10:847
65.
MiragoliMGaudesiusGRohrS.Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ Res2006;
98:801–10
66.
ZhangYKanterEMLaingJGAprhysCJohnsDCKardamiEYamadaKA.Connexin43 expression levels influence intercellular coupling and cell proliferation of native murine cardiac fibroblasts. Cell Commun Adhes2008;
15:289–303
BaumJDuffyHS.Fibroblasts and myofibroblasts: what are we talking about. J Cardiovasc Pharmacol2011;
57:376–9
69.
HinzBPhanSHThannickalVJPrunottoMDesmoulireAVargaJDe WeverOMareelMGabbianiG.Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol2012;
180:1340–55
70.
WeberKTSunYBhattacharyaSKAhokasRAGerlingIC.Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat Rev Cardiol2013;
10:15–26
71.
BeauchampPJacksonCBOzhathilLCAgarkovaIGalindoCLSawyerDBSuterTMZuppingerC.3D co-culture of hiPSC-derived cardiomyocytes with cardiac fibroblasts improves tissue-like features of cardiac spheroids. Front Mol Biosci2020;
7:14
72.
SainiHNavaeiAVan PuttenANikkhahM.3D cardiac microtissues encapsulated with the co-culture of cardiomyocytes and cardiac fibroblasts. Adv Healthc Mater2015;
4:1961–71
73.
GuerzoniLPBTsukamotoYGehlenDBRommelDHarasztiTAkashiMDe LaporteL.A layer-by-layer single-cell coating technique to produce injectable beating mini heart tissues via microfluidics. Biomacromolecules2019;
20:3746–54
74.
LiYAsfourHBursacN.Age-dependent functional crosstalk between cardiac fibroblasts and cardiomyocytes in a 3D engineered cardiac tissue. Acta Biomater2017;
55:120–30
75.
HsiehPCHDavisMELisowskiLKLeeRT.Endothelial-cardiomyocyte interactions in cardiac development and repair. Annu Rev Physiol2006;
68:51–66
76.
ShahAM.Paracrine modulation of heart cell function by endothelial cells. Cardiovasc Res1996;
31:847–67
77.
BjarnegårdMEngeMNorlinJGustafsdottirSFredrikssonSAbramssonATakemotoMGustafssonEFässlerRBetsholtzC.Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development2004;
131:1847–57
78.
ZhaoYYSawyerDRBaligaRROpelDJHanXMarchionniMAKellyRA.Neuregulins promote survival and growth of cardiac myocytes: persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes. J Biol Chem1998;
273:10261–9
79.
MeyerDBirchmeierC.Multiple essential functions of neuregulin in development. Nature1995;
378:386–90
80.
BrutsaertDL.Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev2003;
83:59–115
81.
SuriCJonesPFPatanSBartunkovaSMaisonpierrePCDavisSSatoTNYancopoulosGD.Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell1996;
87:1171–80
82.
GiacomelliEMeravigliaVCampostriniGCochraneACaoXvan HeldenRWJGarciaAKMirceaMKostidisSDavisRPvan MeerBJJostCRKosterAJMeiJMiguezDGMulderAALedesma-TerronMPompilioGSalaLSalvatoriDCFSliekerRCSommarivaEde VriesAAFGieraMSemrauSTertoolenLGJOrlovaVVBellinMMummeryCM.Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease. Cell Stem Cell2020;
26:862–79.e11
83.
CampbellSEKatwaLC.Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol1997;
29:1947–58
84.
VarzidehFMahmoudiEPahlavanS.Coculture with noncardiac cells promoted maturation of human stem cell-derived cardiomyocyte microtissues. J Cell Biochem2019;
120:16681–91
85.
CaspiOItzhakiIKehatIGepsteinAArbelGHuberISatinJGepsteinL.In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev2009;
18:161–72
86.
MasumotoHNakaneTTinneyJPYuanFYeFKowalskiWJMinakataKSakataRYamashitaJKKellerBB.The myocardial regenerative potential of three-dimensional engineered cardiac tissues composed of multiple human iPS cell-derived cardiovascular cell lineages. Sci Rep2016;
6:1–10
87.
NarmonevaDAVukmirovicRDavisMEKammRDLeeRT.Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation2004;
110:962–8
88.
EllisBWAcunACanUIZorlutunaP.Human iPSC-derived myocardium-on-chip with capillary-like flow for personalized medicine. Biomicrofluidics2017;
11:024105
89.
HirtMNHansenAEschenhagenT.Cardiac tissue engineering : state of the art. Circ Res2014;
114:354–67
90.
KolanowskiTJAntosCLGuanK.Making human cardiomyocytes up to date: derivation, maturation state and perspectives. Int J Cardiol2017;
241:379–86
91.
VeldhuizenJMigrinoRQNikkhahM.Three-dimensional microengineered models of human cardiac diseases. J Biol Eng2019;
13:29–41
92.
SantoniSMWinstonTHoangPMaZ.Microsystems for electromechanical stimulations to engineered cardiac tissues. Microphysiol Syst2018;
2:11
93.
KinneyMAHookwayTAWangYMcDevittTC.Engineering three-dimensional stem cell morphogenesis for the development of tissue models and scalable regenerative therapeutics.Ann Biomed Eng2014;
42:352–67
94.
EyckmansJChenCS.3D culture models of tissues under tension. J Cell Sci2017;
130:63–70
95.
AriyasingheNRLyra-LeiteDMMcCainML.Engineering cardiac microphysiological systems to model pathological extracellular matrix remodeling. Am J Physiol Heart Circ Physiol2018;
315:H771–H789
96.
Patino-GuerreroAVeldhuizenJZhuWMigrinoRQNikkhahM.Three-dimensional scaffold-free microtissues engineered for cardiac repair. J Mater Chem B2020;
8:7571–90
97.
CorreiaCKoshkinADuartePHuDCaridoMSebastiãoMJGomes-AlvesPElliottDADomianIJTeixeiraAPAlvesPMSerraM.3D aggregate culture improves metabolic maturation of human pluripotent stem cell derived cardiomyocytes. Biotechnol Bioeng2018;
115:630–44
98.
FleischerSJahnkeHGFritscheEGirardMRobitzkiAA.Comprehensive human stem cell differentiation in a 2D and 3D mode to cardiomyocytes for long-term cultivation and multiparametric monitoring on a multimodal microelectrode array setup. Biosens Bioelectron2019;
126:624–31
99.
LaBargeWMattappallySKannappanRFastVGPretoriusDBerryJLZhangJ.Maturation of three-dimensional, hiPSC-derived cardiomyocyte spheroids utilizing cyclic, uniaxial stretch and electrical stimulation. PLoS One2019;
14:e0219442
MurtuzaBNicholJWKhademhosseiniA.Micro- and nanoscale control of the cardiac stem cell niche for tissue fabrication. Tissue Eng Part B Rev2009;
15:443–54
102.
DingMAnderssonHMartinssonSSabirshAJonebringAWangQDPlowrightATDrowleyL.Aligned nanofiber scaffolds improve functionality of cardiomyocytes differentiated from human induced pluripotent stem cell-derived cardiac progenitor cells. Sci. Rep2020;
10:13575
103.
KhanMXuYHuaSJohnsonJBelevychAJanssenPMLGyorkeSGuanJAngelosMG.Evaluation of changes in morphology and function of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) cultured on an aligned-nanofiber cardiac patch. PLoS One2015;
10:e0126338
104.
WanjareMHouLNakayamaKHKimJJMezakNPAbilezOJTzatzalosEWuJCHuangNF.Anisotropic microfibrous scaffolds enhance the organization and function of cardiomyocytes derived from induced pluripotent stem cells. Biomater Sci2017;
5:1567–78
105.
LeitolisARobertAWPereiraITCorreaAStimamiglioMA.Cardiomyogenesis modeling using pluripotent stem cells: the role of microenvironmental signaling. Front Cell Dev Biol2019;
7:164
106.
AhmedREAnzaiTChanthraNUosakiH.A brief review of current maturation methods for human induced pluripotent stem cells-derived cardiomyocytes. Front Cell Dev Biol2020;
8:178
107.
ShaheenNShitiAHuberIShinnawiRArbelGGepsteinASetterNGoldfrachtIGruberAChornaSVGepsteinL.Human induced pluripotent stem cell-derived cardiac cell sheets expressing genetically encoded voltage indicator for pharmacological and arrhythmia studies. Stem Cell Rep2018;
10:1879–94
108.
KaiserNJKantRJMinorAJCoulombeKLK.Optimizing blended collagen-fibrin hydrogels for cardiac tissue engineering with human iPSC-derived cardiomyocytes. ACS Biomater Sci Eng2019;
5:887–99
109.
RogersAJKannappanRAbukhalifehHGhazalMMillerJMEl-BazAFastVGSethuP.Hemodynamic stimulation using the biomimetic cardiac tissue model (BCTM) enhances maturation of human induced pluripotent stem cell-derived cardiomyocytes. Cells Tissues Organs2019;
206:82–94
110.
SchwanJKwaczalaATRyanTJBartulosORenYSewananLRMorrisAHJacobyDLQyangYCampbellSG.Anisotropic engineered heart tissue made from laser-cut decellularized myocardium. Sci. Rep2016;
6:1–12
111.
ShaoYSangJFuJ.On human pluripotent stem cell control: the rise of 3D bioengineering and mechanobiology. Biomaterials2015;
52:26–43
112.
CharbeNBZacconiFCAmnerkarNPardhiDShuklaPMukattashTLMcCarronPATambuwalaMM.Emergence of three dimensional printed cardiac tissue: opportunities and challenges in cardiovascular diseases. Curr Cardiol Rev2019;
15:188–204
113.
GaoLKupferMEJungJPYangLZhangPDa SieYTranQAjetiVFreemanBTFastVGCampagnolaPJOgleBMZhangJ.Myocardial tissue engineering with cells derived from human-induced pluripotent stem cells and a native-like, high-resolution, 3-dimensionally printed scaffold. Circ Res2017;
120:1318–25
114.
JangJ.3D bioprinting and in vitro cardiovascular tissue modeling. Bioengineering2017;
4:71–91
115.
KupferMELinW-HRavikumarVQiuKWangLGaoLBhuiyanDBLenzMAiJMahutgaRRTownsendDZhangJMcAlpineMCTolkachevaEGOgleBM.In situ expansion, differentiation, and electromechanical coupling of human cardiac muscle in a 3D bioprinted, chambered organoid. Circ Res2020;
127:207–24
116.
LubitzSAYiBAEllinorPT.Genetics of atrial fibrillation. Cardiol Clin2009;
27:25–33
117.
ZhangYSArneriABersiniSShinSRZhuKGoli-MalekabadiZAlemanJColosiCBusignaniFDell’ErbaVBishopCShupeTDemarchiDMorettiMRasponiMDokmeciMRAtalaAKhademhosseiniA.Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials2016;
110:45–59
118.
LianXHsiaoCWilsonGZhuKHazeltineLBAzarinSMRavalKKZhangJKampTJPalecekSP.Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical wnt signaling. Proc Natl Acad Sci U S A2012;
109:E1848–57
119.
SharmaALiGRajarajanKHamaguchiRBurridgePWWuSM.Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation. J Vis Exp2015;
97:e52628
120.
Kita-MatsuoHBarcovaMPrigozhinaMSalomonisMWeiKJacotJGNelsonBSpieringSHaverslag KimCTalantovaMBajpaiRCalzolariDTerskikhAMcCullochADPriceJHConklinBRChenHSVMercolaM.Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One2009;
4:e5046
121.
UosakiHFukushimaHTakeuchiAMatsuokaSNakatsujiNYamanakaSYamashitaJK.Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One2011;
6:e23657
